FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

Florida Hosts in 2017
May 23, 2016

Executive Director Allison Dudley, Board Chair Debra Glass, Board Vice Chair Mark Mikhael and Board members Jeffrey Mesaros and Jeenu Philip attended… Continue reading


FDA MedWatch-New Safety Warnings for Opioids
April 8, 2016

FDA MedWatch – Opioid Pain Medicines: Drug Safety Communication – New Safety Warnings Added to Prescription Opioid Medications ISSUE: FDA is warning about several safety issues with the entire class of opioid pain medicines. See the FDA Drug Safety Communication … Continue reading